Kotynia Justyna, Kordek Radzislaw, Kozlowska Alicja, Malecka-Panas Ewa
Department of Digestive Tract Diseases, Medical University of Lodz, Kopcinskiego 22, Lodz 90-153, Poland.
Int J Gastrointest Cancer. 2005;36(3):121-30. doi: 10.1385/IJGC:36:3:121.
The intestinal type of gastric cancer is thought to originate from cancer precursor lesions, progressing from H. pylori-induced chronic gastritis, atrophic gastritis, to intestinal metaplasia (IM) and dysplasia. Tyrosine kinases (tyr-k) represent the family of proteins that are widely expressed during cell metabolism and are considered as secondary markers for cellular proliferation and malignant transformation.
The aim of the study was to evaluate the correlation between gastric mucosal histopathologic changes, total tyrosine kinases, and proliferative activities in patients with H. pylori infection.
Biopsy specimens from the gastric mucosa of 94 patients were assessed for H. pylori infection, histopathology (according to the Sydney classification), proliferative activity [Ki-67 immunohistochemistry with labeling index (LI) estimation], and total tyr-k activities (ELISA assay kit).
Total tyr-k activities and Ki-67 LI were significantly higher in H. pylori (+) than H. pylori (-) group (728.1 +/- 175.3 vs 360.1 +/- 44.4 pmol P/mg/min. p <0,01 and 20.0 +/- 5.8 vs 10.9 +/- 1.3 %, respectively). A significant correlation has been observed between the Ki-67 LI and total tyr-k activities in patients with and without H. pylori infection. In cases of gastritis accompanied with atrophic changes or intestinal metaplasia in H. pylori (+) patients, Ki-67 LI and total tyr-k activities were particularly high compared to chronic gastritis without atrophy or intestinal metaplasia.
Those results suggest that tyrosine kinases may play an important role in the development of gastric mucosal hyperproliferation in H. pylori-induced gastritis and possibly in early phase of gastric carcinogenesis.
肠型胃癌被认为起源于癌前病变,从幽门螺杆菌诱导的慢性胃炎、萎缩性胃炎发展为肠化生(IM)和发育异常。酪氨酸激酶(tyr-k)是在细胞代谢过程中广泛表达的蛋白质家族,被视为细胞增殖和恶性转化的次要标志物。
本研究旨在评估幽门螺杆菌感染患者胃黏膜组织病理学变化、总酪氨酸激酶和增殖活性之间的相关性。
对94例患者胃黏膜活检标本进行幽门螺杆菌感染、组织病理学(根据悉尼分类法)、增殖活性[采用标记指数(LI)估计的Ki-67免疫组织化学]和总tyr-k活性(ELISA检测试剂盒)评估。
幽门螺杆菌阳性组的总tyr-k活性和Ki-67 LI显著高于幽门螺杆菌阴性组(分别为728.1±175.3对360.1±44.4 pmol P/mg/min,p<0.01;20.0±5.8对10.9±1.3%)。在有和没有幽门螺杆菌感染的患者中,均观察到Ki-67 LI与总tyr-k活性之间存在显著相关性。在幽门螺杆菌阳性患者中,伴有萎缩性改变或肠化生的胃炎病例,与无萎缩或肠化生的慢性胃炎相比,Ki-67 LI和总tyr-k活性特别高。
这些结果表明,酪氨酸激酶可能在幽门螺杆菌诱导的胃炎胃黏膜过度增殖的发展中以及可能在胃癌发生的早期阶段发挥重要作用。